Skip to main content
NVDA+0.35%AAPL-0.21%GOOGL+0.59%MSFT-0.53%AMZN+0.04%TSM-1.68%SPCX+0.43%AVGO-0.97%META-0.25%TSLA+0.05%SKHY-5.20%MU+0.17%BRK-B+0.06%LLY-0.10%JPM-0.32%WMT-0.09%AMD-3.36%V-0.05%XOM+0.61%ASMLa-1.66%JNJ-0.27%INTC-5.57%MA-0.38%0700.HK-1.94%1398.HK+0.79%ABBV+1.62%BAC-0.18%ORCL-5.23%CVX-0.50%CSCO-1.82%COST-0.02%KO+0.32%LRCX-5.65%CAT-1.29%AP2d-1.55%0005.HK-0.78%AMAT-3.17%HSBA.L-1.30%UNH-1.22%PG+0.25%DELL-5.35%GE-0.39%MS-1.22%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.03%HD-1.53%0939.HK+1.66%GS-0.88%NZDJPY-2.56%AUDJPY-1.80%CHFJPY-1.58%NZDCAD-1.40%NZDUSD-1.35%EURNZD+1.34%GBPNZD+1.27%GBPJPY-1.26%EURJPY-1.22%USDJPY-1.19%CADJPY-1.15%NZDCHF-0.95%AUDNZD+0.78%AUDCAD-0.68%AUDUSD-0.61%USDTHB+0.60%EURAUD+0.59%GBPAUD+0.54%CADCHF+0.42%GBPTRY+0.41%USDCHF+0.40%EURCHF+0.36%GBPHKD+0.32%GBPCHF+0.32%USDTRY+0.30%GBPMXN-0.28%AUDCHF-0.24%USDILS+0.16%GBPCAD-0.12%USDCNH+0.09%EURCAD-0.07%GBPUSD-0.06%USDCAD-0.04%EURUSD-0.04%USDCOP-0.04%EURGBP+0.04%USDHKD+0.01%USDNOK0.00%EURSEK0.00%GBPSGD0.00%GBPZAR0.00%CHFNOK0.00%EURPLN0.00%PLNJPY0.00%NZDMXN0.00%EURNOK0.00%NZDSGD0.00%EURCZK0.00%SGDJPY0.00%NOKJPY0.00%AUDSGD0.00%USDMXN0.00%EURDKK0.00%USDSEK0.00%USDZAR0.00%EURHKD0.00%AUDNOK0.00%EURCNH0.00%EURZAR0.00%EURSGD0.00%USDDKK0.00%USDPLN0.00%AUDDKK0.00%CHFSGD0.00%CHFSEK0.00%USDSGD0.00%GAGUSD0.00%HG10.00%S10.00%USOIL0.00%W10.00%XAGUSD0.00%XAUUSD0.00%C10.00%XNGUSD0.00%COCOA0.00%COFFEE0.00%COTTON0.00%BTCUSD-1.40%ETHUSD-0.30%USDTUSD-0.02%XRPUSD-2.98%SOLUSD-1.59%TRXUSDT+0.24%ZECUSDT-8.97%DOGEUSD-2.43%XMRUSDT-0.50%LINKUSD-2.06%XLMUSD-2.24%BCHUSDT-10.23%LTCUSD-1.60%UNIUSD-1.82%TONUSD+24.88%HBARUSDT-1.75%SUIUSD-4.16%TAOUSDT-5.64%AAVEUSD-2.53%DOTUSDT-0.67%ICPUSDT+0.58%ONDOUSDT-3.40%WLDUSDT-3.39%ATOMUSDT-2.89%ARBUSDT-1.63%JUPUSDT-2.53%INJUSDT-2.46%STXUSDT-4.89%FETUSDT-2.36%TIAUSDT-2.18%PYTHUSDT-0.25%SEIUSDT-6.02%IMXUSDT-3.85%WIFUSDT-5.38%GRTUSDT-3.50%OPUSDT-4.00%POLUSDT-4.92%IOTAUSDT-4.23%AXSUSDT-2.36%FARTCOINUSDT-3.29%EOSUSDT-2.29%DYDXUSDT-1.42%ORDIUSDT-1.07%GALAUSDT-3.65%NOTUSDT-2.97%RONINUSDT-2.64%NVDA+0.35%AAPL-0.21%GOOGL+0.59%MSFT-0.53%AMZN+0.04%TSM-1.68%SPCX+0.43%AVGO-0.97%META-0.25%TSLA+0.05%SKHY-5.20%MU+0.17%BRK-B+0.06%LLY-0.10%JPM-0.32%WMT-0.09%AMD-3.36%V-0.05%XOM+0.61%ASMLa-1.66%JNJ-0.27%INTC-5.57%MA-0.38%0700.HK-1.94%1398.HK+0.79%ABBV+1.62%BAC-0.18%ORCL-5.23%CVX-0.50%CSCO-1.82%COST-0.02%KO+0.32%LRCX-5.65%CAT-1.29%AP2d-1.55%0005.HK-0.78%AMAT-3.17%HSBA.L-1.30%UNH-1.22%PG+0.25%DELL-5.35%GE-0.39%MS-1.22%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.03%HD-1.53%0939.HK+1.66%GS-0.88%NZDJPY-2.56%AUDJPY-1.80%CHFJPY-1.58%NZDCAD-1.40%NZDUSD-1.35%EURNZD+1.34%GBPNZD+1.27%GBPJPY-1.26%EURJPY-1.22%USDJPY-1.19%CADJPY-1.15%NZDCHF-0.95%AUDNZD+0.78%AUDCAD-0.68%AUDUSD-0.61%USDTHB+0.60%EURAUD+0.59%GBPAUD+0.54%CADCHF+0.42%GBPTRY+0.41%USDCHF+0.40%EURCHF+0.36%GBPHKD+0.32%GBPCHF+0.32%USDTRY+0.30%GBPMXN-0.28%AUDCHF-0.24%USDILS+0.16%GBPCAD-0.12%USDCNH+0.09%EURCAD-0.07%GBPUSD-0.06%USDCAD-0.04%EURUSD-0.04%USDCOP-0.04%EURGBP+0.04%USDHKD+0.01%USDNOK0.00%EURSEK0.00%GBPSGD0.00%GBPZAR0.00%CHFNOK0.00%EURPLN0.00%PLNJPY0.00%NZDMXN0.00%EURNOK0.00%NZDSGD0.00%EURCZK0.00%SGDJPY0.00%NOKJPY0.00%AUDSGD0.00%USDMXN0.00%EURDKK0.00%USDSEK0.00%USDZAR0.00%EURHKD0.00%AUDNOK0.00%EURCNH0.00%EURZAR0.00%EURSGD0.00%USDDKK0.00%USDPLN0.00%AUDDKK0.00%CHFSGD0.00%CHFSEK0.00%USDSGD0.00%GAGUSD0.00%HG10.00%S10.00%USOIL0.00%W10.00%XAGUSD0.00%XAUUSD0.00%C10.00%XNGUSD0.00%COCOA0.00%COFFEE0.00%COTTON0.00%BTCUSD-1.40%ETHUSD-0.30%USDTUSD-0.02%XRPUSD-2.98%SOLUSD-1.59%TRXUSDT+0.24%ZECUSDT-8.97%DOGEUSD-2.43%XMRUSDT-0.50%LINKUSD-2.06%XLMUSD-2.24%BCHUSDT-10.23%LTCUSD-1.60%UNIUSD-1.82%TONUSD+24.88%HBARUSDT-1.75%SUIUSD-4.16%TAOUSDT-5.64%AAVEUSD-2.53%DOTUSDT-0.67%ICPUSDT+0.58%ONDOUSDT-3.40%WLDUSDT-3.39%ATOMUSDT-2.89%ARBUSDT-1.63%JUPUSDT-2.53%INJUSDT-2.46%STXUSDT-4.89%FETUSDT-2.36%TIAUSDT-2.18%PYTHUSDT-0.25%SEIUSDT-6.02%IMXUSDT-3.85%WIFUSDT-5.38%GRTUSDT-3.50%OPUSDT-4.00%POLUSDT-4.92%IOTAUSDT-4.23%AXSUSDT-2.36%FARTCOINUSDT-3.29%EOSUSDT-2.29%DYDXUSDT-1.42%ORDIUSDT-1.07%GALAUSDT-3.65%NOTUSDT-2.97%RONINUSDT-2.64%
VT

Voyager Therapeutics, Inc. (VYGR)

NASDAQ • Healthcare

$3.19
-$0.06 (-1.8%)
Market closed

Last close at September 10, 2026 at 20:00 UTC

Open$3.19
Day Range$3.13 - $3.21
Avg. Volume (3M)438.5K
Market Cap$192.7M
52 Week Range
$2.94$5.55
Next EarningsIn 60 daysNov 9, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$3.1M100%
Gross Profitminus cost of goods$3.1M100%

Fundamentals & Financials

Revenue (TTM)
$34.4M
Net Income (TTM)
-$107.7M
EPS (TTM)
-$1.81
ROA (TTM)
-54.48%
Current Ratio
7.51

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+14.8%Q1 2026-$0.46
+13.0%Q2 2026-$0.47
+17.3%Q3 2026-$0.4
Next

Nov 9

in 60 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

View full earnings history

About Voyager Therapeutics, Inc.

Voyager Therapeutics, Inc. is a NASDAQ-listed biotechnology company that develops adeno-associated virus-based gene therapy programs and platform technologies for neurological diseases. In FY2025, it recorded $40.4 million in revenue. Its pipeline centers on candidates for Parkinson's disease, ALS, Huntington's disease, and Friedreich's ataxia, alongside broader programs in tauopathies and spinal muscular atrophy.

Name
Voyager Therapeutics, Inc.
CEO
Alfred W. Sandrock Jr.
Website
www.voyagertherapeutics.com
Industry
Healthcare
Year Founded
2013
Employees
141

Today's Snapshot

AI-generated

VYGR closed 1.9% lower at 3.19, in line with a weaker sector.

Trading Volume

Below 10d avg (430.9K)

334.1K

vs S&P 500 Today

Underperforming Market

-1.28%

Updated: September 10, 2026 at 20:19 UTC

Technical Indicators

0 Buy3 Neutral5 Sell
At 3.19, VYGR displays clear technical weakness as virtually all short-, medium- and long-term moving averages sit above the market and momentum skews negative with CCI deeply oversold and short-term momentum declining. RSI remains below neutral and MACD is near flat, while trend strength is muted with ADX around 13, suggesting limited conviction behind recent moves. On-balance volume has fallen, reinforcing distribution, and volatility is moderate with ATR roughly five percent of the price. Pivot levels sit above the current price and act as nearby resistance. Technical takeaway: Sell.
All signals
  • EMA (5 indicators)$3.36 - $3.77
    Sell
  • RSI (14)42.33
    Neutral
  • Stochastic %K (14, 3, 3)25.72
    Neutral
  • MACD Level (12, 26)0.02
    Neutral

Peers & Related Assets

ALLOAllogene Therapeutics, Inc.
$1.76+1.7%
AVIRAtea Pharmaceuticals, Inc.
$5.18-1.7%
ARCTArcturus Therapeutics Holdings Inc.
$13.98-5.2%
ENTAEnanta Pharmaceuticals, Inc.
$12.7-4.1%
VNDAVanda Pharmaceuticals Inc.
$5.04-4.0%
TRDAEntrada Therapeutics, Inc.
$6.42-9.7%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.